MARKET

CDMO

CDMO

Avid Bioservices
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.07
+0.04
+0.18%
Closed 16:00 09/24 EDT
OPEN
21.85
PREV CLOSE
22.03
HIGH
22.32
LOW
21.24
VOLUME
466.93K
TURNOVER
--
52 WEEK HIGH
28.36
52 WEEK LOW
6.99
MARKET CAP
1.35B
P/E (TTM)
268.46
1D
5D
1M
3M
1Y
5Y
Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
Avid Bioservices (CDMO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks · 09/14 14:00
48 Biggest Movers From Yesterday
Gainers
Benzinga · 09/10 09:16
INGN, MTEX and AVCT among mid-day movers
Gainers: Gevo (NASDAQ:GEVO) +35%. American Virtual Cloud Technologies (NASDAQ:AVCT) +33%. Rocket Lab (NASDAQ:RKLB) +32%. Torrid (NYSE:CURV) +30%. Montauk (NASDAQ:MNTK) +25%. Impel (NASDAQ:IMPL) +22%. Gold Royalty (NYSE:GROY) +22%. ProQR (NASDAQ:PRQR) +21%.
Seekingalpha · 09/09 17:00
ProQR Therapeutics, Centessa Pharmaceuticals leads healthcare gainers; Humanigen, Invacare among major losers
Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals (NASDAQ:CNTA) +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech (NASDAQ:TRIB) +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen (NASDAQ:HGEN) -54%, Invacare (N...
Seekingalpha · 09/09 14:59
Update: Avid Bioservices Fiscal Q1 Earnings, Revenue Rise; Shares Sink
MT Newswires · 09/09 14:43
BRIEF-Avid Bioservices Q1 Earnings Per Share $0.10
reuters.com · 09/08 20:25
Avid Bioservices Q1 EPS $0.10 Beats $0.04 Estimate, Sales $30.80M Beat $27.81M Estimate
Avid Bioservices (NASDAQ:CDMO) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.04 by 150 percent. This is a 66.67 percent increase over earnings of $0.06 per share from the
Benzinga · 09/08 20:10
Earnings Reaction History: Avid Bioservices Inc, 70.0% Follow-Through Indicator, 13.2% Sensitive
MT Newswires · 09/08 12:36
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CDMO. Analyze the recent business situations of Avid Bioservices through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CDMO stock price target is 28.25 with a high estimate of 29.00 and a low estimate of 27.00.
EPS
Institutional Holdings
Institutions: 212
Institutional Holdings: 57.48M
% Owned: 93.71%
Shares Outstanding: 61.34M
TypeInstitutionsShares
Increased
53
7.53M
New
28
1.47M
Decreased
58
3.01M
Sold Out
16
889.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.45%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Non-Executive Chairman/Independent Director
Joseph Carleone
President/Chief Executive Officer/Director
Nicholas Green
Chief Financial Officer
Daniel Hart
Chief Operating Officer
Richard Richieri
Vice President/General Counsel/Secretary
Mark Ziebell
Director
Richard Hancock
Independent Director
Esther Alegria
Independent Director
Catherine Mackey
Independent Director
Gregory Sargen
Independent Director
Jeanne Thoma
Declaration Date
Dividend Per Share
Ex-Div Date
03/07/2018
Dividend USD 0.6563
03/16/2018
About CDMO
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Webull offers kinds of Avid Bioservices Inc stock information, including NASDAQ:CDMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDMO stock methods without spending real money on the virtual paper trading platform.